Expert Market Access Strategy Consulting Services

Expert market access strategy consulting services can help you navigate the complex landscape of healthcare markets. This type of consulting involves analyzing market data and trends to identify opportunities for growth.

Market access strategy consulting services typically include analyzing market data and trends to identify opportunities for growth. A thorough understanding of the market is essential to developing an effective market access strategy.

Developing a market access strategy requires a deep understanding of the local healthcare market, including the healthcare system, regulatory environment, and payer landscape. A market access strategy consultant can help you understand these factors and develop a plan to succeed.

By partnering with a market access strategy consulting firm, you can gain access to expertise and resources that would be difficult to replicate in-house. This can be especially beneficial for smaller companies or those new to the market.

Developing a successful market access strategy is crucial for pharmaceutical companies to ensure their products reach patients who need them. This involves navigating a complex landscape of payers, physicians, and regulatory bodies.

Deloitte's Market Access Excellence (MAx) Framework is a valuable tool for cross-functional brand teams to align on strategic choices and enhance patient access throughout the product life cycle. The framework consists of six core principles and 10 interdependent "must-answer" choices that guide market access strategy development.

To succeed in this landscape, companies must consider factors such as value-based contracting, pricing strategy, and government programs. They must also be prepared to adapt to changes in the access paradigm, such as the emergence of biosimilars and new stakeholders.

Here are some key considerations for market access strategy:

A market access strategy is crucial for biopharmaceutical companies to ensure their products reach patients who need them. It involves understanding the complex landscape of healthcare systems, identifying opportunities, and developing effective plans to overcome access barriers.

Developing a comprehensive market access strategy requires a deep understanding of the target market, including the needs and expectations of key stakeholders such as payers, physicians, and patients. This involves conducting thorough market research, analyzing data, and identifying key drivers of access.

To craft a winning market access strategy, companies can follow the six core principles of Deloitte's Market Access Excellence (MAx) Commercial framework, which guides the development of a market access strategy for assets in Phase 2 through launch and post-launch. These principles include following a rigorous and disciplined approach, starting with what matters most to access stakeholders, developing an overarching value strategy, building in flexibility, making conscious tradeoffs, and ensuring alignment and coordination with overarching brand strategy.

A well-designed market access strategy should also consider the unique needs and challenges of different therapeutic areas, such as the impact of biosimilars or emerging stakeholders. This requires a deep understanding of the therapeutic area, including the disease burden, patient needs, and market dynamics.

Some of the key elements of a market access strategy include:

By following these principles and incorporating these key elements, companies can develop effective market access strategies that help their products reach patients who need them.

IQVIA was named the highest positioned Leader by Everest Group in the 2023 Life Sciences Sales and Marketing Operations PEAK Matrix Assessment.

The assessment evaluated 17 life sciences sales and marketing operations providers serving the industry.

IQVIA was the highest-scoring provider named in the Leader category.

This recognition is a testament to IQVIA's expertise and capabilities in life sciences sales and marketing operations.

The PEAK Matrix Assessment is a rigorous evaluation process that helps organizations choose the right partner for their needs.

IQVIA's leadership position in this assessment is a significant achievement and a reflection of their commitment to excellence.

This achievement is a valuable asset for life sciences companies looking for a trusted partner in sales and marketing operations.

For more insights, see: Life Science Strategy Consulting

Cloud technology has enabled businesses to access new markets with greater ease. With cloud infrastructure, companies can quickly scale up or down to meet changing market demands.

One of the key benefits of cloud technology is its flexibility. Cloud computing allows businesses to rent computing resources and storage on a pay-as-you-go basis. This means companies can quickly adapt to changing market conditions without having to make significant upfront investments.

Cloud technology has also made it easier for businesses to access new markets by reducing the need for physical infrastructure. According to a report, 70% of companies are now using cloud-based solutions to expand their global reach.

Recommended read: Cloud Strategy Consulting

Our consulting services can help you navigate the complex process of gaining market access. This involves extensive research, including clinical trials to provide evidence of efficacy and safety, as well as real-world studies to demonstrate product value beyond efficacy.

We can assist you in developing effective pricing and reimbursement plans, and reduce time to market by early planning. This allows you to assess the market landscape, anticipate potential challenges, and identify mitigation strategies.

Our integrated evidence generation plan creates a roadmap for clinical and real-world evidence generation, addressing knowledge gaps and outlining evidence needs at every stage of development. This helps optimize timely and successful market access.

Here are some of the key services we offer:

Our consulting process is designed to help you navigate the complex landscape of market access. We begin by assessing the market landscape to anticipate potential challenges and identify mitigation strategies.

Early planning is key to reducing time to market. By developing an integrated evidence generation plan, we can create a roadmap for clinical and real-world evidence generation.

This integrated plan addresses knowledge gaps and outlines evidence needs at every stage of development. Our team works with you to optimize timely, successful market access.

We also provide integrated scientific advice, which provides feedback from regulatory and HTA stakeholders. This guidance helps you make informed decisions and adjust your development plans to meet stakeholder needs.

Our strategic planning approach spans the access continuum, meeting global and local stakeholder requirements and expectations. By working with us, you can ensure your product is ready for market access.

Here are the key components of our consulting process:

Early payer engagement and landscape assessment are crucial steps in ensuring the successful market access of your pharmaceutical product. This process involves understanding the market landscape and anticipating potential challenges.

Market access can be a lengthy process, requiring extensive research, including clinical trials and real-world studies to demonstrate product value. By engaging with payers early on, you can validate your study designs and optimize clinical trial design.

The process of gaining market access can be lengthy and requires extensive research. Early planning allows companies to assess the market landscape, anticipate potential challenges, and identify mitigation strategies. This can be done through market access landscape assessment and due diligence support.

To achieve strong, optimized strategic planning, it's essential to partner with experienced market access consultants. They can help you develop an integrated evidence generation plan that creates a roadmap for clinical and real-world evidence generation.

Here are some key benefits of early payer engagement and landscape assessment:

Our team has expertise in various areas that are crucial to developing a successful market access strategy. We have a deep understanding of the complexities involved in each of these areas.

We have extensive experience in agriculture and food security, which is essential for businesses looking to expand into new markets. Our knowledge of economic growth and trade allows us to navigate the intricacies of international trade agreements and regulations.

See what others are reading: How to Trade in Forex Market

Our capabilities also extend to supply chain consulting and strategy, where we help businesses optimize their logistics and distribution channels. This expertise is vital for ensuring timely and efficient delivery of products to market.

Here are some of the key areas where our expertise shines:

At our organization, we pride ourselves on being experts in drug commercialization, helping our clients achieve their market access goals through rigorous and disciplined approaches.

We follow the Core MAx principles, which include developing and evolving competitive market access strategies, starting with what matters most to access stakeholders, and building in flexibility to adapt to changing market conditions.

Our MAx Commercial platform allows organizational functions to use a common language, providing consistency in developing and communicating market access activities throughout the product life cycle.

We use a structured process to define and quantify a value story that will help our clients' brands achieve their market access goals, including disease burden quantification, stakeholder value driver mapping, value catalog development, and value price quantification.

You might like: What Does Market Value Mean in Stocks

Here are the key steps in our process:

By following this process, we've helped our clients gain cross-functional alignment on the value story framework, value differentiating opportunities, and the evidence requirements to enable their brand's value story, ultimately informing their pricing strategy with a value price view.

Check this out: Customer Value Driven Marketing Strategy

Developing a winning market access strategy is crucial for late-stage clinical and in-line brands. According to Deloitte's Market Access Excellence (MAx) Commercial framework, there are six core principles that guide the development of such a strategy.

The first principle is to follow a rigorous and disciplined approach to develop, evaluate, and evolve competitive market access strategies. This involves a systematic and structured approach to ensure that the strategy is comprehensive and effective.

The second principle is to start with what matters most to access stakeholders, such as payers, PBMs, IDNs, and channel partners. This involves understanding their needs and priorities to develop a value strategy that resonates with them.

To develop an overarching value strategy, you need to use a comprehensive set of market access levers. This includes understanding the therapeutic area, brand context, and changes in the access paradigm.

Building in flexibility to adapt to changes in the access paradigm is also essential. This includes being prepared to adapt to new stakeholders, such as biosimilars, and emerging stakeholders.

Making conscious tradeoffs in pursuit of sustainable, profitable market access is another key principle. This involves balancing competing priorities and making decisions that align with the brand's overall strategy.

Finally, ensuring alignment and coordination with overarching brand strategy is critical. This involves working closely with cross-functional teams to ensure that the market access strategy is aligned with the brand's overall goals and objectives.

Here are the six core principles of the MAx Commercial framework:

IQVIA's V&A Team offers end-to-end support across the globe, providing deep expertise in clinical to commercial functions in multiple therapeutic areas.

Their highly-trained market access experts have global and local expertise, allowing them to navigate complex market access challenges.

With proprietary data, technology, and advanced analytics, IQVIA helps clients bring innovative therapies to patients.

Their Market Access Planning (MAP) Tool is a web-based solution that allows users to create and monitor personalized market access plans for a global portfolio.

The tool improves organizational communication and efficacy, making it easier to navigate the market access roadmap.

Here are some of the key services offered by IQVIA's V&A Team:

The MAP Tool is a web-based platform that helps navigate the market access roadmap. It's a comprehensive solution that allows users to create and monitor personalized market access plans for their entire global portfolio.

This tool improves organizational communication and efficacy, which is a game-changer for companies looking to expand their reach. By streamlining their market access planning, they can make more informed decisions and stay ahead of the competition.

The MAP Tool is designed to be user-friendly, making it easy for anyone to create and manage market access plans. This is especially important for companies with limited resources or expertise in market access planning.

Iqvia's V&A Team provides end-to-end support across the globe, spanning clinical to commercial functions in multiple therapeutic areas.

Their expertise is powered by highly-trained market access experts with global and local expertise.

Iqvia's V&A Team can help you bring innovative therapies to patients through proprietary data, technology, and advanced analytics and methodologies.

They can outline global strategic pricing, reimbursement, market access, and funding flows.

Here are some specific ways Iqvia's V&A Team can support you:

Iqvia's V&A Team can also inform and create compelling clinical and commercial evidence to maximize and demonstrate value to access stakeholders globally and locally.

They can track, forecast, and respond to market and policy evolutions across the globe at industry, portfolio, and asset level.

Staying on top of the latest market trends is crucial for business leaders to make informed decisions. Our team provides the latest insights that can help business leaders make better decisions.

Business leaders can explore our featured news and insights to gain a deeper understanding of the market access strategy consulting landscape. This will help them navigate the complex world of market access strategy consulting.

By staying informed, business leaders can make more informed decisions and drive growth in their organizations.

For another approach, see: How to Start a Consulting Business

The Inflation Reduction Act (IRA) is having a significant impact on the life sciences industry, and it's essential to understand its implications. The IRA is a landmark legislation that's disrupting the industry and making it challenging for many brands to predict their future expectations.

The IRA is being interpreted and analyzed by the IQVIA U.S. Market Access Center of Excellence, which is providing valuable insights to help brands position their products for success. These insights are crucial for companies to navigate the changing landscape and make informed decisions.

The IRA is expected to have a lasting impact on the industry, and it's essential for brands to stay up-to-date with the latest developments and trends. By doing so, they can adjust their strategies and ensure their products remain competitive in the market.

Staying informed is key to making smart business decisions. Our Featured Insights and News section is designed to keep you up to date with the latest news and trends.

You can explore the latest insights and news to help business leaders make better decisions. This is where you'll find the most relevant and timely information to inform your decisions.

By staying current with the latest news and insights, you can anticipate and respond to changes in the market. This helps you stay ahead of the curve and make informed decisions.

Our Featured Insights and News section is regularly updated to ensure you have access to the most current information. This means you can rely on us for the latest news and insights.

You can explore the latest news and insights to help you make better decisions and stay ahead of the competition.

At Resonance, we believe that strong partnerships and a fulfilling career are key to success. Our partnerships development team excels at Strategy Development, Opportunity Mapping, Design & Facilitation, Adaptive Management, Sustaining & Scaling Impact, and Partnership Training.

If you're looking to join our team, you'll find a supportive and dynamic work environment at Resonance. Our employee benefits are designed to promote work-life balance and well-being.

Here are some of the benefits you can expect as an employee:

At Resonance, you can expect a unique and supportive work environment that fosters growth and collaboration. Life at Resonance is all about embracing a culture of innovation and teamwork.

If you're looking for a company that truly values its employees, Resonance is the place to be. Employee Benefits are comprehensive and designed to support your well-being and career goals.

Here are some of the key benefits you can expect at Resonance:

Resonance is committed to delivering a compelling Employee Value Proposition that aligns with your values and aspirations. By joining the team, you'll have the opportunity to make a meaningful impact and contribute to the company's mission.

As a professional, having the right partners can make all the difference in your career. We're expert partnership builders with deep networks in emerging markets.

Our team helps clients develop local partnerships for supply and distribution, which can be a game-changer for businesses looking to expand globally. We're also skilled at creating cross-sector and pre-competitive partnerships to address shared market risk and opportunity.

We offer a range of services to support our clients' partnership development, including strategy development, opportunity mapping, and design & facilitation. This means we can help clients identify and pursue new partnership opportunities, and design and implement effective partnerships.

Our partnership development services also include adaptive management, sustaining & scaling impact, and partnership training. This ensures that our clients' partnerships are well-managed, effective, and sustainable over time.

Here are some of the specific services we offer:

Growth is a crucial phase in market access strategy consulting. It's time to scale up and reach more patients.

To determine the best model for growth, we work with clients to incorporate learnings from initial market entry. This involves conducting rapid analyses to assess and select new markets and geographies for expansion.

Adapting marketing, distribution, HR, and investment strategies is also essential for growth. Developing new partnerships to accommodate expanded reach and operations is another key consideration.

By following this approach, companies can successfully expand their reach and operations, and deliver new treatments to more patients.

Optimizing market access is crucial for the success of innovative health technologies.

To drive patient access and maximize value for healthcare stakeholders, a well-constructed and implemented evidence-generation plan is essential.

A strong value proposition and evidentiary support are necessary to ensure that even the most innovative interventions reach their intended users – the patients.

Common challenges in innovative health technology development include garnering insights to reduce risk, robust evidence plan expectations from regulatory and HTA bodies, competitive threats, and growing and changing regulatory, HTA, and payer restrictions.

To overcome these challenges, our market access team leverages deep relationships with HTA bodies, regulators, and payers in established and emerging markets.

This expertise allows us to provide actionable strategies to drive and demonstrate payer value throughout the development life cycle.

Here are some key areas where we can help optimize access and uptake:

By partnering with us, you can achieve strong, optimized strategic planning for long-term success, including an integrated evidence generation plan and integrated scientific advice.

Navigating the complexities of global market access requires a deep understanding of local and regional requirements. The Inflation Reduction Act in the United States, for instance, has shifted the focus towards cost containment and ROI.

The European market demands rigorous standards for value demonstration, with health technology assessments (HTAs) influencing not only European policy but also the US. Products must showcase both clinical value and economic worth.

In APAC, Japan commits to HTAs, while China's regionalized approach means varying assessment requirements. This highlights the need for adaptability in navigating the Asian market.

To succeed in global market access, companies must develop tailored strategies that address local and regional needs. This includes understanding regulatory frameworks, meeting clinical data requirements, and adapting to region-specific market dynamics.

Here are some key considerations for global market access:

Companies must also stay informed and collaborate with stakeholders to overcome challenges and seize opportunities. This includes developing an evidence generation plan and value proposition development to support pricing and access assumptions.